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The feasibility of using biochemical assays of ytglutamyltranspeptidase (y-GTP) and N-hydroxy-N-2-fluorenylacetamide sulfotransferase (N-OH-2-FAA
ST) activities to monitor the effects of treatment of male Sprague-Dawley rats with a two-stage hepatocarcinogenic regimen was investigated. One
week after initiation with diethylnitrosamine (200 mg/kg of bw), the rats were treated with 10 oral doses within 2 weeks of N-2-fluorenylacetamide
(2-FAA) at 0.05 mmole/kg or vehicle (corn oil) at 5 ml/kg of body weight. After five doses of 2-FAA or corn oil, half of the rats in each group under-
went partial (70%) hepatectomy (PH). Three days after completion of 2-FAA treatment, y-GTP activity increased approximately 8-fold in the livers of
both the nonhepatectomized (-PH) and hepatectomized (+PH) groups. After 17 days, the enzyme activity decreased to the control level in the -PH
group but increased 3.1-fold above the control level in the +PH group. After 31, 66, and 87 days, ytGTP activity increased only 1.4- to 2.6-fold in the
-PH group, whereas that of +PH group increased 15- to 32-fold. N-OH-2-FAA ST activity, determined 3 days after completion of 2-FAA treatment,
decreased by approximately 60% in the -PH and +PH groups. After 17 days, the effect of PH became evident in that the losses of N-OH-2-FAA ST
activity were smaller (20%) in the -PH than in the +PH group (45.5%). After 31, 66, and 87 days, the respective decreases of 27, 29, and 41 % in the
+PH group were significant. Nodules excised from the livers of the +PH group 87 days after treatment with 2-FAA showed 25% of N-OH-2-FAA ST
activity of the control livers. The data suggested that early increases in ytGTP and decreases in N-OH-2-FAA ST activities, which were independent
of PH, were affected by hepatic metabolism of 2-FAA. After 17 days, the presumed clearance of 2-FAA, the effect of PH was manifested in that it
prevented return to control levels of both enzyme activities in 2-FAA-treated rats. The time and PH dependency of the extent of modulations of -t
GTP and N-OH-2-FAA ST activities support their assays as markers of the promotion/progression of hepatocarcinogenesis. -Environ Health
Perspect 102(Suppl 6):105-108 (1994)
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Introduction
Two-stage models for studies of initiation
and promotion of hepatocarcinogenesis
(HC) in the rat include the Solt-Farber
protocol employing diethylnitrosamine
(DEN) as a single dose initiator and N-2-
fluorenylacetamide (2-FAA) at 0.02% in
diet as promoter (1). Although the mecha-
nism of tumor promotion by 2-FAA is not
as yet clearly understood, the available evi-
dence strongly suggests that normal hepa-
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tocytes are more susceptible to cytotoxic
effects of2-FAA-derived metabolite(s) than
DEN-initiated preneoplastic cells, which
results in preferential growth of the latter
(2). Partial hepatectomy (PH), usually per-
formed during the course oftreatment with
the promoter, provides a stimulus to cell
proliferation. Promotion usually has been
monitored by histochemical and/or bio-
chemical determinations of the increased
expression of y-glutamyltranspeptidase (y-
GTP) since y-GTP-positive foci ofthe ini-
tiated cells increase in size (volume), but
not number, in response to a promoter (3).
In the liver ofthe susceptible male rat, the
suspected cytotoxic metabolite of 2-FAA is
formed via N-hydroxylation to N-hydroxy-
N-2-fluorenylacetamide (N-OH-2-FAA)
and sulfation of the latter to N-O-sulfate.
The extremely reactive N-O-sulfate of N-
OH-2-FAA binds to DNA and causes liver
necrosis (4). N-O-Sulfation is catalyzed by
N-OH-2-FAA sulfotransferase (ST) (5), an
isozyme of arylsulfotransferase IV (6).
Inhibition of ST by pentachlorophenol in
vivo resulted in decreased volume ofhepatic
y-GTP-positive foci in DEN-initiated rats
treated with N-OH-2-FAA, suggesting that
N-O-sulfate has a role in promotion (7).
Decreases in N-OH-2-FAA ST activity
following administration of 2-FAA have
been reported by several investigators
(5,6,8-11). The enzyme assays were usually
carried out during or within 1 week after
completion of treatment with 2-FAA.
Ringer et al. (6) found that N-OH-2-FAA
ST activity returned to the level of intact
liver within 1 week following feeding of 2-
FAA at subcarcinogenic levels. However,
carcinogenic regimens of 2-FAA led to a
permanent decrease in N-OH-2-FAA ST
activity, and the resulting nodules and
tumors were devoid of the enzyme. This
suggested that a decrease in N-OH-2-FAA
ST activity might be progressive and serve
as a marker of promotion/progression of
HC. Hence, in this study, we examined N-
OH-2-FAA ST activity in the livers of rats
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at timed intervals within a 12-week period
following treatment with a modified Solt-
Farber regimen of two-stage HC. The
modification, based on the protocol
employed by Moller et al. (12), concerned
replacement of2-FAA-containing diet with
intragastric intubations of 2-FAA in corn
oil. In parallel assays, we determined y-
GTP activity, an established marker ofpro-
motion ofHC (3). We also determined the
effect ofPH, performed in the middle ofa
2-week treatment with 2-FAA, on both
enzyme activities.
Materials and Methods
Chemicals
DEN, p-nitrophenylsulfate, 3',5'-adeno-
sine diphosphate, 'y-L-glutamyl-p-
nitroanilide, glycylglycine, sodium nitrite,
N-i-naphthylethylenediamine, and corn
oil were from Sigma Chemical Co. (St.
Louis, MO). Metofane (methoxyflurane)
was from Pittman-Moore (Mundelein, IL).
2-FAA, melting point 192 to 1960C, was
from Aldrich (Milwaukee, WI). N-OH-2-
FAA, melting point 150 to 151°C, was
prepared by the published method (13). 2-
FAA and N-OH-2-FAA were recrystallized
until pure by HPLC.
TreatmentofRats andPreparation
ofLiver
Male Sprague-Dawley rats, 6 weeks old,
weighing 150 to 174 g (Harlan Sprague-
Dawley, Inc., Indianapolis, IN), were
maintained on a pelleted semisynthetic
30% casein diet (Teklad Premier Diets,
Madison, WI) and water ad libitum. After
1 week, the rats were given a single ip
injection ofDEN, 200 mg/kg bw, in saline.
One week later, the rats started a 2-week
treatment of 10 intragastric intubations of
2-FAA in corn oil at 0.05 mmole/kg or
corn oil at 5 ml/kg ofbody weight (Figure
1). Three days after completion of five
doses of 2-FAA or corn oil, halfofthe rats
in each group underwent PH (70%) under
Metofane anesthesia. On day 3 after PH,
the treatment resumed. On the days shown
in Figure 1, rats from each group were
killed by decapitation under CO2, and liv-
ers were removed. After washing with ice-
cold saline, livers were homogenized in 4
volumes of 50 mM Tris-HCl 154 mM
KCl buffer, pH 7.4, as described previously
(14). Whole homogenates and the cytosolic
fractions (105,000g supernatants) were
used for enzyme assays. The protein con-
tent was determined by the method of
Lowry et al. (15) with a bovine serum albu-
min standard.
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Figure 1. Experimental protocol. Initiation consisted of a single ip injection of DEN, 200 mg/kg of body weight, in
saline, to 50-day-old male rats. Promotion consisted of ten intragastric doses of 2-FAA in corn oil at a dose level of
0.05 mmole/kg of body weight. Control rats received corn oil at a dose level of 5 ml/kg of body weight. Three days
after five doses of 2-FAA or corn oil, half of the rats in each group underwent partial (70%) hepatectomy (PH). The
enzyme activity was determined in individual livers of two to four rats on the days shown. * denotes enzyme
assay in the livers removed during PH.
EnzymeAssays
,y-GTP activity was determined according
to the method ofIgarashi et al. (16). [The
final volume consisted of0.5 ml 100 mM
Tris-HCl buffer, pH 7.4, containing y-L-
glutamyl-p-nitroanilide (0.051 mM) as the
substrate, and glycylglycine (1.1 mM) as
the acceptor for the glutamyl group
released by y-GTP of liver homogenate
(0.6 mg protein).] After 20 min at 37°C
the liberated p-nitroaniline was diazotized
with 0.1% sodium nitrite and 0.05% N-1-
naphthylethylenediamine to a pink azo dye
measured spectrally at 540 nm. The activ-
ity ofy-GTP was calculated from a stan-
dard curve obtained with p-nitroaniline
and expressed as nmole ofp-nitroaniline per
minute permiligram protein.
N-OH-2-FAA ST activity was deter-
mined in cytosolic fractions by the proce-
dure ofRinger and Norton (17). Briefly, in
a final volume of0.5 ml, p-nitrophenylsul-
fate (10 mM), 3',5'-adenosine diphosphate
(0.02 mM) in 100 mM Tris-HCl buffer,
pH 8.0, 0.3 mg cytosolic protein, and the
acceptor substrate, N-OH-2-FAA (0.55
mM) in ethanol (5%), were mixed in a
cuvette, and the increase in absorbance ofp-
nitrophenol at 405 nm (£, 18,380
M- cm- ) was recorded every 30 sec at
31°C for 10 min, during which time the
rates were linear. Control incubations con-
tained 5% ethanol without N-OH-2-FAA.
The rate ofp-nitrophenol formed in the
control was subtracted from the rate mea-
sured with N-OH-2-FAA as the acceptor.
The activity of N-OH-2-FAA ST was
expressed as nmole ofp-nitrophenol per
minute per miligram protein.
Duplicate assays were carried out with
liver preparations from two to four rats per
each time point. The data were analyzed
using Student's two sample t-test. The level
ofsignificance was set either atp<0.005 or
p<0.05.
Results
Following treatment of rats with DEN
(one dose) and 2-FAA (10 doses), accord-
ing to the regimen in Figure 1, the average
cumulative dose of2-FAAwas 0.125 mmole
per rat. This regimen had no significant
effect on the weight gain of rats except for
temporary (-2-day) decreases of <10%
bodyweight following ip injection ofDEN
and PH. On day 66 after completion of
treatment with 2-FAA, the livers had many
tiny nodules (<1 mm diameter), which
increased to 2 to 3 mm diameter, some to 3
to 5 mm, by day 87. The largest nodules
were excised for determination of enzyme
activities. The levels ofhepatic y-GTP and
N-OH-2-FAA ST activities assayed on
days 3, 17, 31, 66, and 87 (including nod-
ules) after completion of 2-FAA treatment
are shown in Figures 2 and 3, respectively.
y-GTP activity determined 3 days after
completion of 2-FAA treatment showed
significant increases, 9.5- and 7.4-fold,
respectively, in the livers of both -PH and
+PH rats. On day 17 after the treatment,
the enzyme activity in the -PH rats had
returned to the control level but was 3.1-
fold above the control level in the livers of
+PH rats. On days 31, 66, and 87 after
treatment with 2-FAA, y-GTP activity had
increased only 1.4- to 2.6-fold in the livers
of-PH rats; whereas, it had increased 15-
to 32-fold in the livers of +PH rats. The
level ofy-GTP on day 87 was similar in the
nodules and the nodular liver.
N-OH-2-FAA ST activity was inversely
affected compared to y-GTP within the
same time frame. N-OH-2-FAA ST activity
also significantly decreased (by 48%) 3 days
after five doses of2-FAA; whereas that ofy-
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Figure 2. Hepatic y-GTP activity in nonhepatectomized
(-PH) and hepatectomized (+PH) rats treated with a
two-stage regimen of DEN + 2-FAA or DEN + corn oil.
Treatment of rats and enzyme assay are described in
"Materials and Methods." The values are the means of
duplicate assays from two to four livers ± SD.
a (p<0.005) or b(p<0.05) denotes significant differ-
ences between DEN + 2-1FAA- and DEN + corn oil-
treated rats. * denotes the enzyme assay in the livers
removed during PH.
GTP was as yet unaffected. Three days after
completion of2-FAA treatment (10 doses),
N-OH-2-FAA ST activity significantly
decreased by 55 and 62% in the -PH and
+PH rats, respectively. On day 17 after the
completion of 2-FAA treatment, the effect
ofPH started to become evident in that the
decreases of N-OH-2-FAA ST activity,
although still significant, were smaller
(20%) in the -PH than +PH rats (45.5%).
On days 31 and 66 only the decreases in the
+PH rats of27 and 29%, respectively, were
significant. By day 87 N-OH-2-FAA ST
activity in the livers of +PH and -PH
groups had decreased by 41 and 16%,
respectively. The nodules found only in 2-
FAA-treated +PH group had 25% of N-
OH-2-FAA ST activity ofthe control liver.
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Figure 3. Hepatic N-OH-2-FAA ST activity in nonhepa-
tectomized (-PH) and hepatectomized (+PH) rats
treated with a two-stage regimen of DEN + 2-FAA or
DEN + corn oil. Treatment of rats and enzyme assay are
described in "Materials and Methods." The values are
the means of duplicate determinations from two to four
livers ± SD. a (p 0.005) or b(p 0.05) denotes signifi-
cant differences between DEN + 2-FAA- and DEN +
corn oil-treated rats. * denotes the enzyme assay in
the livers removed during PH.
Discussion
Following treatment of male rats with
DEN (1 dose) and 2-FAA (10 doses), the
effect of PH on the increase in hepatic y-
GTP and decrease in N-OH-2-FAA ST
activities (Figures 2, 3) was time-depen-
dent. At 3 days after the completion of
treatment, the changes in these activities
were independent of PH. Between 3 and
17 days or 3 and 31 days after the treatment,
y-GTP or N-OH-2-FAA ST activities,
respectively, approached the levels ofcon-
trol livers, especially in -PH rats. Later,
between 31 and 87 days after the treatment,
greater differences in activities between
DEN + 2-FAA- and DEN + corn oil-treated
rats were determined in the +PH groups.
The data suggested that the early and late
responses to 2-FAA treatment, differing in
dependency on PH, are mediated by differ-
ent mechanisms.
The early increases in y-GTP activity in
the livers of DEN + 2-FAA-treated rats of
both -PH and +PH groups suggested an
increased rate ofdetoxication involving the
y-glutamyl cycle (18). The progressively
larger increases ofy-GTP activity deter-
mined at later stages after treatment with
2-FAA of +PH rats reflected an increase in
volume ofy-GTP-positive foci (nodules)
and confirmed the enzyme as a marker of
promotion/progression ofHC (3).
The early decreases in N-OH-2-FAA
ST activity in the livers of DEN + 2-FAA-
treated rats of both -PH and +PH groups
may result from inactivation ofthe enzyme
by the reaction product, N-O-sulfate ofN-
OH-2-FAA (19). The decreases in N-OH-
2-FAA ST activity determined at later
stages may be due to the progressive devel-
opment of nodules observed between 66
and 87 days after completion of 2-FAA
treatment of +PH rats. Although the nod-
ules contained 25% ofN-OH-2-FAA ST
activity of the control liver, this might
result from contamination by extra-nodular
liver tissue, since Ringer et al. (6) showed
that 2-FAA-derived hepatic nodules and
tumors were devoid of N-OH-2-FAA ST
activity and the corresponding protein.
The mechanism of irreversible loss of this
enzyme activity in hepatocellular carcinoma
is not yet understood. However, it has been
postulated, especially for +PH rats, that the
decrease in sulfation activity towards N-
OH-2-FAA in (pre)neoplastic cells is due
to their high rate of proliferation rather
than genetic changes (20).
The inverse modulation of y-GTP and
N-OH-2-FAA ST activities determined
between 4 and 12 weeks (31 and 87 days)
in the livers ofrats exposed to PH and the
modified Solt-Farber regimen of HC sug-
gested that these enzymes are useful markers
of promotion/progression of HC and the
above time period is suitable for mechanistic
studies ofHC at the molecular level.
REFERENCES
1. Solt DB, Medline A, Farber E. Rapid emergence ofcarcinogen-
induced hyperplastic lesions in a new model for the sequential
analysis of liver carcinogenesis. AmJ Pathol 88:595-618
(1977).
2. Farber E. The biochemistry ofpreneoplastic liver: a common
metabolic pattern in hepatocyte nodules. Can J Biochem Cell
Biol 62:486-494 (1984).
3. Pitot HC, Glauert HP, Hanigan M. The significance of
selected biochemical markers in the characterization ofputative
initiated cell populations in rodent liver. Cancer Lett 29:1-14
(1985).
4. Shirai T, King CM. Sulfotransferase and deacetylase in normal
and tumor-bearing liver ofCD rats: autoradiographical studies
with N-hydroxy-2-acetylaminofluorene and N-hydroxy-4-
acetylaminobiphenyl in vitro and in vivo. Carcinogenesis
3:1385-1391 (1982).
Volume 102, Supplement 6, October 1994 107VIJAYARAGHAVANANDMALEJKA-GIGANTI
5. DeBaun JR, Miller EC, Miller JA. N-Hydroxy-2-acetylamino-
fluorene sulfotransferase: its probable role in carcinogenesis and
in protein-(methion-S-yl) binding in rat liver. Cancer Res
30:577-595 (1970).
6. Ringer DP, Norton TR, Howell BA. 2-Acetylaminofluorene-
mediated alteration in the level ofliver arylsulfotransferase IV
during rat hepatocarcinogenesis. Cancer Res 50:5301-5307
(1990).
7. Kroese ED, van de Poll MLM, Mulder GJ, Meerman JHN.
The role of N-sulfation in the N-hydroxy-2-acetylamino-
fluorene-mediated outgrowth of diethylnitrosamine-initiated
hepatocytes to y-glutamyltranspeptidase-positive foci in male
rat liver. Carcinogenesis 9:1953-1958 (1988).
8. Jackson CD, Irving CC. Sex differences in cell proliferation and
N-hydroxy-2-acetylaminofluorene sulfotransferase levels in rat
liver during 2-acetylaminofluorene administration. Cancer Res
32:1590-1594 (1972).
9. Ringer DP, Kampschmidt K, King RLJr, Jackson S, Kizer DE.
Rapid decrease in N-hydroxy-2-acetylaminofluorene sulfotrans-
ferase activity of liver cytosols from rats fed carcinogen.
Biochem Pharmacol 32:315-319 (1983).
10. Blanck A, Wicksell L, Eriksson LC. Sulfation ofN-hydroxy-2-
acetylaminofluorene in normal and nodular liver from male
Wistar rats. Toxicol Pathol 15:103-105 (1987).
11. Ringer DP, Norton TR, Cox B, Howell BA. Changes in rat
liver N-hydroxy-2acetylaminofluorene aryl sulfotransferase
activity at early and late stages ofhepatocarcinogenesis resulting
from dietary administration of2-acetylaminofluorene. Cancer
Lett 40:247-255 (1988).
12. M6ller L, Torndal U-B, Eriksson LC, Gustafsson JA. The air
pollutant 2-nitrofluorene as initiator and promoter in a liver
model for chemical carcinogenesis. Carcinogenesis 10:435-440
(1989).
13. Miller EC, Miller JA, Hartmann HA. N-Hydroxy-2-acety-
laminofluorene: a metabolite of 2-acetylaminofluorene with
increased carcinogenic activity in the rat. Cancer Res
21:815-824 (1961).
14. Malejka-Giganti D, Decker RW, Ritter CL, Polovina MR.
Microsomal metabolism of the carcinogen, N-2-fluorenylacet-
amide, by the mammary gland and liver offemale rats. I. Ring-
and N-hydroxylations ofN-2-fluorenylacetamide. Carcinogenesis
6:95-103 (1985).
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein mea-
surement with the Folin phenol reagent. J Biol Chem
193:265-275 (1951).
16. Igarashi T, Satoh T, Ueno K, Kitagawa H. Sex-related differ-
ences in the hepatic glutathionelevel and related enzyme activi-
ties in rat. J Biochem (Tokyo) 93:33-36 (1983).
17. Ringer DP, Norton TR. Further characterization ofthe ability
of hepatocarcinogens to lower rat liver aryl sulfotransferase
activity. Carcinogenesis 8:1749-1752 (1987).
18. Ketterer B, Coles B, Meyer DJ. The role of glutathione in
detoxication. Environ Health Perspect 49:59-69 (1983).
19. Mangold BLK, Erickson J, Lohr C, McCann DJ, Mangold JB.
Self-catalyzed irreversible inactivation of rat hepatic aryl sulfo-
transferase IV by N-hydroxy-2-acetylaminofluorene.
Carcinogenesis 11:1563-1567 (1990).
20. Gilissen,RAHJ, Meerman JHN. Bioactivation ofthe hepatocar-
cinogen N-hydroxy-2-acetylaminofluorene by sulfation in the
rat liver changes during the cell cycle. Life Sciences
51:1255-1260 (1992).
108 Environmental Health Perspectives